{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:00:54Z","timestamp":1791320454206,"version":"4.3.1"},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T00:00:00Z","timestamp":1253577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Partial Rh antigens have been widely described in black individuals. Carriers are prone to immunization when exposed to the normal antigens. In sickle cell disease (SCD), patient alloimmunization is a major cause of transfusion failure. The potential of individuals with partial C antigen to make anti\u2010C has not been investigated. We sought partial C status and anti\u2010C production in a cohort of SCD patients with the C+ phenotype, to determine whether exposure to normal C antigen should be avoided.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> We constituted a cohort of 177 randomly selected SCD patients expressing C antigen. We screened for <jats:italic>(C)ce<jats:sup>s<\/jats:sup><\/jats:italic> and <jats:italic>R<jats:sup>N<\/jats:sup><\/jats:italic> haplotypes, presumably associated with partial C antigen in Afro\u2010Caribbeans, and we recorded the number of transfused C+ red blood cell (RBC) units, immunization status, and extended phenotype.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> Forty\u2010nine patients carried abnormal C antigen, deduced from the presence of <jats:italic>(C)ce<jats:sup>s<\/jats:sup><\/jats:italic> and\/or <jats:italic>R<jats:sup>N<\/jats:sup><\/jats:italic>, not compensated by a normal <jats:italic>RHC<\/jats:italic> allele in trans. Among patients with partial C phenotype exposed repeatedly to C+ RBCs, 30% produced anti\u2010C. Two patients experienced hemolysis. In our hospital, with 22% of SCD patients expressing C, prevention of anti\u2010C immunization for all individuals with partial C antigen would require a 7% increase in the use of C\u2013 RBC units. These RBCs are already in short supply for SCD patients who are C\u2013.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> This study demonstrates the need to detect partial C within C+ SCD patients and to prevent immunization. A larger number of Afro\u2010Caribbeans donors is needed to provide these patients with C\u2013 RBCs.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2009.02382.x","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T14:29:27Z","timestamp":1253629767000},"page":"13-19","source":"Crossref","is-referenced-by-count":68,"title":["Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization"],"prefix":"10.1111","volume":"50","author":[{"given":"Christophe","family":"Tournamille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Meunier\u2010Costes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Costes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Martret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Barrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Galact\u00e9ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Nzou\u00e9kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bierling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Noizat\u2010Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1397"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)00099-8"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-005-1419-5"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12074"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(03)00042-9"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0229"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02802.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1182\/blood.V110.11.455.455","article-title":"RH gene polymorphisms are risk factor for allo\u2010immunization in patients with sickle cell disease","volume":"110","author":"Westhoff CM","year":"2007","journal-title":"Blood"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.11.4853.bloodjournal87114853"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37197176949.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2008.02.001"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2008.10.002"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.00658.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328313695e"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20959"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02129.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2009.02382.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2009.02382.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T16:47:22Z","timestamp":1697302042000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2009.02382.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1537-2995.2009.02382.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02382.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}